Evogene Ltd. (TLV:EVGN)
Israel · Delayed Price · Currency is ILS · Price in ILA 264.20
+7.90 (3.08%)
At close: Mar 13, 2026
Evogene Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 3.85 | 8.51 | 5.64 | 1.68 | 0.93 | |
Revenue Growth (YoY) | -54.73% | 50.90% | 236.72% | 80.11% | -10.58% |
Cost of Revenue | 4.09 | 2.68 | 1.69 | 0.91 | 0.77 |
Gross Profit | -0.24 | 5.83 | 3.95 | 0.77 | 0.16 |
Selling, General & Admin | 5.76 | 10.87 | 9.68 | 10.42 | 9.99 |
Research & Development | 7.99 | 16.65 | 20.78 | 20.79 | 21.13 |
Other Operating Expenses | 0.04 | 0.52 | - | -3.5 | - |
Operating Expenses | 13.79 | 28.04 | 30.46 | 27.71 | 31.12 |
Operating Income | -14.03 | -22.21 | -26.51 | -26.94 | -30.95 |
Interest Expense | -1.89 | -0.06 | -0.12 | -0.17 | -0.32 |
Interest & Investment Income | - | 0.96 | 1.25 | 0.18 | 0.29 |
Earnings From Equity Investments | -0.04 | -0.04 | - | - | - |
Currency Exchange Gain (Loss) | - | -0.05 | -0.25 | -1.74 | 1.07 |
Other Non Operating Income (Expenses) | 2.47 | 3.36 | -0.16 | -0.25 | -0.46 |
EBT Excluding Unusual Items | -13.5 | -18.04 | -25.78 | -28.92 | -30.37 |
Gain (Loss) on Sale of Investments | - | - | 0.05 | -0.72 | -0.06 |
Other Unusual Items | - | -0 | -0.25 | -0.11 | - |
Pretax Income | -13.5 | -18.05 | -25.99 | -29.75 | -30.43 |
Income Tax Expense | 0 | 0.01 | -0.03 | 0.09 | 0.01 |
Earnings From Continuing Operations | -13.5 | -18.05 | -25.95 | -29.84 | -30.45 |
Earnings From Discontinued Operations | 5.67 | - | - | - | - |
Net Income to Company | -7.83 | -18.05 | -25.95 | -29.84 | -30.45 |
Minority Interest in Earnings | -0.66 | 1.57 | 2.08 | 3.21 | 2.65 |
Net Income | -8.49 | -16.49 | -23.88 | -26.64 | -27.79 |
Net Income to Common | -8.49 | -16.49 | -23.88 | -26.64 | -27.79 |
Shares Outstanding (Basic) | 8 | 6 | 5 | 4 | 4 |
Shares Outstanding (Diluted) | 8 | 6 | 5 | 4 | 4 |
Shares Change (YoY) | 38.21% | 24.14% | 10.80% | 2.44% | 43.59% |
EPS (Basic) | -1.08 | -2.89 | -5.20 | -6.43 | -6.87 |
EPS (Diluted) | -1.08 | -2.89 | -5.20 | -6.43 | -6.87 |
Free Cash Flow | -13.64 | -20.33 | -22.36 | -24.85 | -25.56 |
Free Cash Flow Per Share | -1.73 | -3.57 | -4.87 | -6.00 | -6.32 |
Gross Margin | -6.25% | 68.48% | 70.00% | 45.73% | 17.53% |
Operating Margin | -364.24% | -260.96% | -470.00% | -1608.42% | -3328.28% |
Profit Margin | -220.22% | -193.69% | -423.39% | -1590.33% | -2988.49% |
Free Cash Flow Margin | -353.93% | -238.82% | -396.49% | -1483.52% | -2748.71% |
EBITDA | -12.89 | -20.5 | -24.7 | -24.36 | -28.72 |
EBITDA Margin | - | -240.90% | - | - | - |
D&A For EBITDA | 1.14 | 1.71 | 1.81 | 2.58 | 2.23 |
EBIT | -14.03 | -22.21 | -26.51 | -26.94 | -30.95 |
EBIT Margin | - | -260.96% | - | - | - |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.